Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters

Journal of Gene Medicine

Volumn 7, Issue 6, 2005, Pages 803-817

  Pluta, Krzysztof ^a   Luce, Milson J ^a   Bao, Lili ^a   Agha Mohammadi, Siamak ^b   Reiser, Jakob ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Doxycycline; Gene regulation; Lentivirus; Second generation TRE; Tet on

Indexed keywords

BETA GLOBIN; DOXYCYCLINE; LENTIVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TRANSFER; HUMAN; HUMAN CELL; INSULATOR ELEMENT; LONG TERMINAL REPEAT; MOLECULAR CLONING; MOUSE; NONHUMAN; NUDE MOUSE; OPERATOR GENE; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CELL TRANSPLANTATION; CHICKENS; DOXYCYCLINE; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; GENETIC VECTORS; GLOBINS; HELA CELLS; HUMANS; KIDNEY; LENTIVIRUS; MICE; MICE, NUDE; MICE, SCID; OSTEOSARCOMA; PROMOTER REGIONS (GENETICS); SKIN; TETRACYCLINE; TRANS-ACTIVATORS; TRANSGENES; TRANSPLANTATION, HETEROLOGOUS;

LENTIVIRUS; MUS MUSCULUS;

EID: 21044449615     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.712     Document Type: Article

References (64)

1. Agha-Mohammadi S, Lotze MT. Regulatable systems: applications in gene therapy and replicating viruses. J Clin Invest 2000; 105: 1177-1183.
2. Clackson T. Regulated gene expression systems. Gene Ther 2000; 7: 120-125.
3. Toniatti C, Bujard H, Cortese R, et al. Gene therapy progress and prospects: transcription regulatory systems. Gene Ther 2004; 11: 649-657.
4. Corbel SY, Rossi FM. Latest developments and in vivo use of the Tet system: ex vivo and in vivo delivery of tetracycline-regulated genes. Curr Opin Biotechnol 2002; 13: 448-452.
5. Baron U, Bujard H. Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. Methods Enzymol 2000; 327: 401-421.
6. Gossen M, Freundlieb S, Bender G, et al. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766-1769.
7. Kafri T, van Praag H, Gage FH, et al. Lentiviral vectors: regulated gene expression. Mol Ther 2000; 1: 516-521.
8. Vigna E, Cavalieri S, Ailles L, et al. Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors. Mol Ther 2002; 5: 252-261.
9. Regulier E, Pereira de Almeida L, Sommer B, et al. Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease. Hum Gene Ther 2002; 13: 1981-1990.
10. Regulier E, Trottier Y, Perrin V, et al. Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum. Hum Mol Genet 2003; 12: 2827-2836.
11. Reiser J, Lai Z, Zhang XY, et al. Development of multigene and regulated lentivirus vectors. J Virol 2000; 74: 10 589-10 599.
12. Johansen J, Rosenblad C, Andsberg K, et al. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS. Gene Ther 2002; 9: 1291-1301.
13. Koponen JK, Kankkonen H, Kannasto J, et al. Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2(S)-M2 shows a tight control of gene expression in vitro and in vivo. Gene Ther 2003; 10: 459-466.
14. Urlinger S, Baron U, Thellmann M, et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A 2000; 97: 7963-7968.
15. Lamartina S, Roscilli G, Rinaudo CD, et al. Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators. Hum Gene Ther 2002; 13: 199-210.
16. Salucci V, Scarito A, Aurisicchio L, et al. Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2(s)-M2 tetracycline transactivator and repressor system. Gene Ther 2002; 9: 1415-1421.
17. Go WY, Ho SN. Optimization and direct comparison of the dimerizer and reverse tet transcriptional control systems. J Gene Med 2002; 4: 258-270.
18. Chung JH, Whiteley M, Felsenfeld G. A 5′ element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell 1993; 74: 505-514.
19. Wang Y, DeMayo FJ, Tsai SY, et al. Ligand-inducible and liver-specific target gene expression in transgenic mice. Nat Biotechnol 1997; 15: 239-243.
20. Fitzsimons HL, McKenzie JM, During MJ. Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain. Gene Ther 2001; 8: 1675-1681.
21. Steinwaerder DS, Lieber A. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo. Gene Ther 2000; 7: 556-567.
22. Emery DW, Yannaki E, Tubb J, et al. A chromatin insulator protects retrovirus vectors from chromosomal position effects. Proc Natl Acad Sci U S A 2000; 97: 9150-9155.
23. Ma Y, Ramezani A, Lewis R, et al. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 2003; 21: 111-117.
24. Ramezani A, Hawley TS, Hawley RG. Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator. Blood 2003; 101: 4717-4724.
25. Agha-Mohammadi S, O'Malley M, Etemad A, et al. Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness. J. Gene Med 2004; 6: 817-828.
26. DuBridge RB, Tang P, Hsia HC, et al. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 1987; 7: 379-387.
27. Price JE, Polyzos A, Zhang RD, et al. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1990; 50: 717-721.
28. Zhang XY, La Russa VF, Bao L, et al. Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells. Mol Ther 2002; 5: 555-565.
29. Reiser J, Harmison G, Kluepfel-Stahl S, et al. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci U S A 1996; 93: 15 266-15 271.
30. Adachi A, Gendelman HE, Koenig S, et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986; 59: 284-291.
31. Mochizuki H, Schwartz JP, Tanaka K, et al. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J Virol 1998; 72: 8873-8883.
32. Reiser J. Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Ther 2000; 7: 910-913.
33. Chang LJ, McNulty E, Martin M. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms. J Virol 1993; 67: 743-752.
34. Akagi K, Kanai M, Saya H, et al. A novel tetracycline-dependent transactivator with E2F4 transcriptional activation domain. Nucleic Acids Res 2001; 29: E23.
35. Marino MP, Luce MJ, Reiser J. Small- to large-scale production of lentivirus vectors. In Lentivirus Gene Engineering Protocols, Federico M (ed). Humana Press: Totowa, NJ, 2003; 43-55.
36. Julias JG, Ferris AL, Boyer PL, et al. Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase. J Virol 2001; 75: 6537-6546.
37. 32P-based hybridizations. Anal Biochem 1993; 210: 235-244.
38. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 1992; 89: 5547-5551.
39. Sastry L, Johnson T, Hobson MJ, et al. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther 2002; 9: 1155-1162.
40. Zhang XY, La Russa VF, Reiser J. Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins. J Virol 2004; 78: 1219-1229.
41. Oligino T, Poliani PL, Wang Y, et al. Drug inducible transgene expression in brain using a herpes simplex virus vector. Gene Ther 1998; 5: 491-496.
42. Burcin MM, Schiedner G, Kochanek S, et al. Adenovirus-mediated regulable target gene expression in vivo. Proc Natl Acad Sci U S A 1999; 96: 355-360.
43. Sirin O, Park F. Regulating gene expression using self-inactivating lentiviral vectors containing the mifepristone-inducible system. Gene 2003; 323: 67-77.
44. Ho DY, McLaughlin JR, Sapolsky RM. Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system. Brain Res Mol Brain Res 1996; 41: 200-209.
45. Harding TC, Geddes BJ, Noel JD, et al. Tetracycline-regulated transgene expression in hippocampal neurones following transfection with adenoviral vectors. J Neurochem 1997; 69: 2620-2623.
46. Hu SX, Ji W, Zhou Y, et al. Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression. Cancer Res 1997; 57: 3339-3343.
47. Yoshida Y, Hamada H. Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal. Biochem Biophys Res Commun 1997; 230: 426-430.
48. Bohl D, Salvetti A, Moullier P, et al. Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector. Blood 1998; 92: 1512-1517.
49. Rendahl KG, Leff SE, Otten GR, et al. Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nat Biotechnol 1998; 16: 757-761.
50. Chenuaud P, Larcher T, Rabinowitz JE, et al. Optimal design of a single recombinant adeno-associated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle. Mol Ther 2004; 9: 410-418.
51. Paulus W, Baur I, Boyce FM, et al. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol 1996; 70: 62-67.
52. Hofmann A, Nolan GP, Blau HM. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc Natl Acad Sci U S A 1996; 93: 5185-5190.
53. Hwang JJ, Scuric Z, Anderson WF. Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline-responsive expression system. J Virol 1996; 70: 8138-8141.
54. Iida A, Chen ST, Friedmann T, et al. Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system. J Virol 1996; 70: 6054-6059.
55. Verhoef K, Marzio G, Hillen W, et al. Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. J Virol 2001; 75: 979-987.
56. Marzio G, Verhoef K, Vink M, et al. In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies. Proc Natl Acad Sci U S A 2001; 98: 6342-6347.
57. Smith SM, Khoroshev M, Marx PA, et al. Constitutively dead, conditionally live HIV-1 genomes. Ex vivo implications for a live virus vaccine. J Biol Chem 2001; 276: 32 184-32 190.
58. Xiao Y, Kuwata T, Shida H. Dox-dependent SIVmac with tetracycline-inducible promoter in the U3 promoter region. Virology 2000; 269: 268.
59. Rang A, Will H. The tetracycline-responsive promoter contains functional interferon-inducible response elements. Nucleic Acids Res 2000; 28: 1120-1125.
60. Freundlieb S, Schirra-Muller C, Bujard H. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med 1999; 1: 4-12.
61. McGee Sanftner LH, Rendahl KG, Quiroz D, et al. Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina. Mol Ther 2001; 3: 688-696.
62. Lamartina S, Silvi L, Roscilli G, et al. Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primates. Mol Ther 2003; 7: 271-280.
63. Mizuguchi H, Xu ZL, Sakurai F, et al. Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions. Hum Gene Ther 2003; 14: 1265-1277.
64. Vogel R, Amar L, Thi AD, et al. A single lentivirus vector mediates doxycycline-regulated expression of transgenes in the brain. Hum Gene Ther 2004; 15: 157-165.